Prevention of phosphate-induced progression of uremia in rats by 3-phosphocitric acid

Kidney Int. 1982 Jul;22(1):36-41. doi: 10.1038/ki.1982.129.

Abstract

Male Sprague-Dawley rats were rendered uremic by surgical removal of 70% of functioning renal mass. This produced a rapid threefold rise in serum creatinine to 0.87 +/- 0.067 (SEM) mg/dl at 2 weeks postoperatively which declined subsequently to a value of 0.64 +/- 0.06 (SEM) and remained stable thereafter for an additional 4 weeks in animals maintained on a diet with normal phosphate content. Increase of dietary phosphate content to 2.2% at 2 weeks after surgery produced a significant and progressive increase in serum creatinine to values fourfold higher than the mean values in comparable partially nephrectomized control animals maintained on a diet with normal phosphate content (P less than 0.001). This deterioration in renal function was associated with extensive nephrocalcinosis, tubular dilatation, cellular necrosis, and marked interstitial inflammation. 3-phosphocitric acid, a compound which has been shown to prevent calcium phosphate crystal growth as well as to prevent in vivo nephrocalcinosis, was very effective in preventing this phosphate-induced deterioration of renal function and in preventing any significant increase in renal calcium content in animals fed a high phosphate diet. This compound was also effective in preventing the renal histologic changes associated with phosphate-induced uremia.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Calcium / metabolism
  • Citrates / therapeutic use*
  • Creatinine / blood
  • Diet
  • Kidney / pathology
  • Male
  • Microscopy, Electron
  • Nephrectomy
  • Phosphates / administration & dosage
  • Phosphates / adverse effects*
  • Rats
  • Rats, Inbred Strains
  • Uremia / etiology
  • Uremia / pathology
  • Uremia / prevention & control*

Substances

  • Citrates
  • Phosphates
  • phosphocitrate
  • Creatinine
  • Calcium